Literature DB >> 9457515

Immunolocalization of transforming growth factor beta during wound repair in rat retina after laser photocoagulation.

C Yamamoto1, N Ogata, X Yi, K Takahashi, M Miyashiro, H Yamada, M Uyama, K Matsuzaki.   

Abstract

BACKGROUND: Scatter photocoagulation induces regression of retinal neovascularization, but the mechanism of its therapeutic effect is incompletely understood. To elucidate the mechanism of therapeutic effect of photocoagulation is the main focus of our research. We have already demonstrated basic fibroblast growth factor (bFGF) immunolocalization during retinal wound repair following laser photocoagulation. Transforming growth factor beta (TGF beta) reportedly inhibits endothelial cell growth and bFGF-induced cell proliferation in vitro. In the present study, we evaluated the immunohistochemical localization of TGF-beta 1 and -beta 2 during wound repair in the rat retina following laser photocoagulation.
METHODS: Krypton laser photocoagulation was performed on the eyes of pigmented rats. The eyes were then enucleated on day 1, 3, 7, 14, 28 or 56 following the photocoagulation and enrolled into the analysis of immunohistochemical localization of TGF-beta 1 and -beta 2.
RESULTS: Immunoreactivity for TGF-beta 1 and -beta 2 was present in the ganglion cell layer and photoreceptor outer segments of the normal adult rat retina. The cytoplasm of RPE cells at the photocoagulated lesion showed intense TGF-beta 1 and -beta 2 immunoreactivity on day 3 after laser photocoagulation. Macrophages that migrated into the lesion lacked positive staining for TGF-beta 1 and -beta 2. TGF-beta immunoreactivity in RPE cells continued to be upregulated for more than 1 month compared with that in normal RPE cells. Controls did not exhibit any positive staining.
CONCLUSION: An elevated expression of TGF-beta immunoreactivity for a longer period of time than bFGF was observed in RPE cells at the photocoagulated lesion in vivo. In the late phase of retinal wound repair, TGF-beta may inhibit cell proliferation induced by mitogens, introduce an end stage of cellular events, and induce extracellular matrix induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9457515     DOI: 10.1007/s004170050040

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  31 in total

Review 1.  Transforming growth factor beta: biochemistry and roles in embryogenesis, tissue repair and remodeling, and carcinogenesis.

Authors:  A B Roberts; K C Flanders; P Kondaiah; N L Thompson; E Van Obberghen-Schilling; L Wakefield; P Rossi; B de Crombrugghe; U Heine; M B Sporn
Journal:  Recent Prog Horm Res       Date:  1988

2.  Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta.

Authors:  T A Mustoe; G F Pierce; A Thomason; P Gramates; M B Sporn; T F Deuel
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

3.  Inhibitory action of transforming growth factor beta on endothelial cells.

Authors:  G Müller; J Behrens; U Nussbaumer; P Böhlen; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Transforming growth factor-beta inhibits endothelial cell proliferation.

Authors:  M Fràter-Schröder; G Müller; W Birchmeier; P Böhlen
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

5.  Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors.

Authors:  A Baird; T Durkin
Journal:  Biochem Biophys Res Commun       Date:  1986-07-16       Impact factor: 3.575

6.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Transforming growth factor beta levels in rat wound chambers.

Authors:  D T Cromack; M B Sporn; A B Roberts; M J Merino; L L Dart; J A Norton
Journal:  J Surg Res       Date:  1987-06       Impact factor: 2.192

8.  Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye.

Authors:  B A Pfeffer; K C Flanders; C J Guérin; D Danielpour; D H Anderson
Journal:  Exp Eye Res       Date:  1994-09       Impact factor: 3.467

9.  Increased production of transforming growth factor-beta 2 from cultured human retinal pigment epithelial cells by photocoagulation.

Authors:  M Matsumoto; N Yoshimura; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-12       Impact factor: 4.799

10.  Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells.

Authors:  V Baldin; A M Roman; I Bosc-Bierne; F Amalric; G Bouche
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

View more
  4 in total

1.  Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat.

Authors:  W Y Shen; M J Yu; C J Barry; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Subthreshold (retinal pigment epithelium) photocoagulation in macular diseases: a pilot study.

Authors:  J Roider; R Brinkmann; C Wirbelauer; H Laqua; R Birngruber
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

3.  Comparison of the neuroinflammatory responses to selective retina therapy and continuous-wave laser photocoagulation in mouse eyes.

Authors:  Jung Woo Han; Juhye Choi; Young Shin Kim; Jina Kim; Ralf Brinkmann; Jungmook Lyu; Tae Kwann Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-10       Impact factor: 3.117

4.  Per2-Mediated Vascular Dysfunction Is Caused by the Upregulation of the Connective Tissue Growth Factor (CTGF).

Authors:  Vaishnavi Jadhav; Qianyi Luo; James M Dominguez; Jude Al-Sabah; Brahim Chaqour; Maria B Grant; Ashay D Bhatwadekar
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.